Orphan Drugs Market 2020 Global Covid-19 Impact Analysis on Healthcare Sector And Business With Forecast To 2027 is latest Report published by Fortune Business Insights. This report also studies the global Orphan Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The global orphan drugs market size was valued at USD 151.00 billion in 2019 and is projected to reach USD 340.84 billion by 2027, exhibiting a CAGR of 10.5% during the forecast period.
Market for Orphan Drugs is segmented By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027.
Orphan Drugs Market Analysis From 2020 To 2027:
Orphan drugs are used for the treatment of severe and life-threatening diseases. The high emphasis on research and development of these drugs are consequential to the difficulty associated with the treatment of the disease. Due to increasing incidence of such life-threatening diseases, including cancer, there are several companies that are operating across the globe. The high prevalence of infectious diseases in developed as well as developing countries will bode well for the growth of the market in the coming years. The presence of several large scale manufacturers will contribute to the growth of the market. The increasing demand for immunomodulators in emerging as well as developed countries will have a positive impact on the growth of the overall market in the foreseeable future.
Some of the companies operating the industry are:
- Amgen Inc. (Thousand Oaks, U.S.)
- Bayer AG (Leverkusen, Germany)
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Alexion Pharmaceuticals Inc. (Boston, U.S.)
- Novo Nordisk A/S (Bagsværd, Denmark)
- Novartis AG (Basel, Switzerland)
- Bristol-Myers Squibb Company (New York, U.S.)
- AstraZeneca (Cambridge, U.K.)
- DAIICHI SANKYO COMPANY, LIMITED (Tokyo, Japan)
- GlaxoSmithKline plc (Brentford, U.K.)
Global Orphan Drugs Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Orphan Drugs Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. Regionally, this report categorizes the production, apparent consumption, export and import of Orphan Drugs in North America, Europe, China, Japan, Southeast Asia and India.
The report highlights a few of the major industry developments of recent times and discusses their impact on the growth of the overall market. Accounting to the rising investments in product R&D, several drugs have been cleared by organizations such as the European Union and the US Food and Drug Administration. Increasing number of such regulatory approvals will bode well for the growth of the overall market in the coming years. In August 2018, Ultragenyx announced that it has bagged approval from the US Food and Drug Administration for a new orphan drug. The company announced that it received approval for mucopolysaccharidosis VII. The company had previously seamlessly cleared the clinical trials and this drug can help the company a great deal in the coming years. Moreover, this will also encourage other SMEs in the market and subsequently affect the growth of the global market in the coming years.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Global Orphan Drugs Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Orphan Drugs market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
What is the scope of the report?
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Regional Market Overview:
This report focuses on Orphan Drugs Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The Orphan Drugs Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
- Raw material suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research and development (RandD) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Table Of Content:
1 Market Overview
1.1 Orphan Drugs Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
220.127.116.11 United States Market States and Outlook (2014-2024)
18.104.22.168 Canada Market States and Outlook (2014-2024)
22.214.171.124 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
126.96.36.199 Germany Market States and Outlook (2014-2024)
188.8.131.52 France Market States and Outlook (2014-2024)
184.108.40.206 UK Market States and Outlook (2014-2024)
220.127.116.11 Russia Market States and Outlook (2014-2024)
18.104.22.168 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
22.214.171.124 China Market States and Outlook (2014-2024)
126.96.36.199 Japan Market States and Outlook (2014-2024)
188.8.131.52 Korea Market States and Outlook (2014-2024)
184.108.40.206 India Market States and Outlook (2014-2024)
220.127.116.11 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
18.104.22.168 Brazil Market States and Outlook (2014-2024)
22.214.171.124 Egypt Market States and Outlook (2014-2024)
126.96.36.199 Saudi Arabia Market States and Outlook (2014-2024)
188.8.131.52 South Africa Market States and Outlook (2014-2024)
184.108.40.206 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Orphan Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Orphan Drugs Market Analysis by Regions
4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Orphan Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Orphan Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2014-2019)
4.5 South America Orphan Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2014-2019)
5 North America Orphan Drugs by Country
5.1 North America Orphan Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Orphan Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Orphan Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Orphan Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Orphan Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Orphan Drugs Sales and Growth Rate (2014-2019)
8 South America Orphan Drugs by Country
8.1 South America Orphan Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Orphan Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Orphan Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Orphan Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Orphan Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Orphan Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Orphan Drugs by Countries
9.1 Middle East and Africa Orphan Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Orphan Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Orphan Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Orphan Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Orphan Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Orphan Drugs Sales and Growth Rate (2014-2019)
10 Orphan Drugs Market In Developing Conutries
11 South America Orphan Drugs Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Orphan Drugs Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245